Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

NCT02851745 is registered in ClinicalTrials.gov with Heart Care Foundation as lead sponsor.

NCT NCT02851745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02851745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
Lead sponsor
Heart Care Foundation
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2015
Completion date
July 2, 2019
Enrollment
188 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, left ventricular systolic dysfunction